|Day Low/High||165.68 / 167.05|
|52 Wk Low/High||114.27 / 197.00|
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
Let's look closer at the charts and indicators of ABBV.
U.S. equity futures drifted lower Tuesday, setting up the S&P 500 for its first three-day decline since early May, as investors peel back from recent record highs and take a defensive stance on risk ahead of this weekend's G20 Summit in Japan.
AbbVie is dropping on Allergan deal announcement, momentum is weak outside certain pockets.
U.S. stock futures decline as investors take a defensive stance on risk ahead of this weekend's G-20 summit in Japan; Micron reports earnings Tuesday; FedEx, which also reports earnings, sues the U.S. government arguing new trade regulations put an 'impossible burden' on the company to monitor its shipments.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
MAGNETIC MUSCLE STIMULATION TECHNOLOGY TO STRENGTHEN, TONE AND FIRM MUSCLES
The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.
--BOTOX® is the First Neurotoxin Treatment Approved to Treat Pediatric Patients, 2 to 17 Years of Age, with Upper Limb Spasticity--
Aegon will repurchase 32,873,805 common shares to neutralize the dilutive effect of the 2018 final stock dividend.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE:AGN) today announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms in adult patients with IBS-C.
Today, Aegon Bank priced its inaugural EUR 500 million 5 year Senior Non-Preferred notes with a yield of 0.
Approval Based on Totality of Evidence Demonstrating KANJINTI is Biosimilar to Herceptin
A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.
Investors should consider recession-proof names in the current environment, Jim Cramer says.
South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.
Aegon today announces that Sarah Russell (1962, Australian), member of Aegon's Management Board and Global CEO of Aegon Asset Management, will step down.
- New Indication Makes VRAYLAR First and Only Dopamine and Serotonin Partial Agonist to Treat the Full Spectrum of Bipolar I Symptoms in Manic, Mixed, and Depressive Episodes -
DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
DUBLIN, May 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY.
-- Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis --
"With the evolving market conditions, we mutually agreed that the future of the variable annuity business in Japan is best served as a wholly-owned part of our longstanding partner Sony Life", said Alex Wynaendts, CEO of Aegon.
Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.
These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.
DUBLIN, May 16, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
Abstracts will showcase research on VRAYLAR, including a focus on an investigational use for the treatment of bipolar depression
PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce its partnership with Allergan plc on a year-long market research study...
Novartis gets a potentially blockbuster eye drug and Takeda gets to unload some debt and employees it took on when it purchased Shire.
DUBLIN, May 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, Nevada.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.